Always work with your healthcare provider on testing and treatment decisions.
Together, these changes increase the risk of injury, infection, and tissue death (necrosis), contributing to a high rate of toe, foot, and lower leg amputations in people with diabetes
Disclaimer This page is an educational research reference
Typical protocol: Dose: 0.51.5 mg subcutaneously 23x/week Often cycled: 4 weeks on, 2 weeks off Multi-Peptide Blends: KLOW and GLOW Pre-mixed peptide blends like KLOW combine BPC-157, TB-500, and GHK-Cu in a single vial
Some peptides may require 10-15 minutes for full dissolution
If you know you opened the vial more than 28 days ago, it is best to err on the side of caution and discard it